Cancer Research & Clinical Trials

The Froedtert & the Medical College of Wisconsin Cancer Network backs its commitment to the constant search for new and more effective cancer treatments by participating in significant clinical trials for new drugs, radiation therapies, interventional techniques, technologies and surgical procedures. On average, more than 250 adult cancer clinical trials are in process at any given time.

View All Cancer Clinical Trials

The National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN) recently designated the MCW Cancer Center as a Lead Academic Participating Site (LAPS) — one of only 30 institutions in the United States to achieve this designation, and the only institution in Milwaukee and eastern Wisconsin. For cancer patients treated throughout the Froedtert & MCW Cancer Network, the LAPS grant provides researchers with resources, funding and a network of collaboration, discovery and applications available to only the top cancer centers in the country.

Read More About the NCTN LAPS Designation

Our physicians are principal investigators in multi-institution trials in cooperation with the National Cancer Institute. They also work cooperatively with national groups such as the Radiation Therapy Oncology Group, American College of Surgeons Oncology Group, the Eastern Cooperative Oncology Group, the National Surgical Adjuvant Breast and Bowel Project, Gynecologic Oncology Group, Blood and Marrow Transplant Clinical Trials Network and others. We also perform research in cooperation with pharmaceutical companies. In addition, Medical College of Wisconsin scientists and physicians generate research that is completely unique to Froedtert & the Medical College.

The objective of conducting clinical trials is to improve the broad spectrum of cancer care, encompassing not only diagnosis and treatment, but prevention as well. These activities put the Clinical Cancer Center in a research leadership position that provides direct benefit in terms of new treatment options and improved quality of life for our cancer patients.